Cargando…
Specificity may be overrated in cancer immunotherapy: Getting to know the nonspecific side of memory T Cells
For a long time, cancer immunotherapy has focused on the induction of tumor-specific T cell-mediated immune responses. Now, a mounting body of evidence indicates that efficient anticancer immune responses also rely on innate immunity. Tietze et al. have recently elucidated an antigen-nonspecific rol...
Autores principales: | Sckisel, Gail D., Murphy, William J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494648/ https://www.ncbi.nlm.nih.gov/pubmed/23170282 http://dx.doi.org/10.4161/onci.20779 |
Ejemplares similares
-
Combinatorial Immunotherapy: PD-1 may not be LAG-ing behind any more
por: Turnis, Meghan E., et al.
Publicado: (2012) -
Impact of aging in cancer immunotherapy: The importance of using accurate preclinical models
por: Bouchlaka, Myriam N, et al.
Publicado: (2013) -
Bioreactors get personal
por: Somerville, Robert P.T., et al.
Publicado: (2012) -
MAGE-A3-specific anticancer immunotherapy in the clinical practice
por: Brichard, Vincent G, et al.
Publicado: (2013) -
Split T-cell tolerance as a guide for the development of tumor antigen-specific immunotherapy
por: Tsuji, Takemasa, et al.
Publicado: (2012)